MENU

Can Axon Enterprise (AXON) Stock Reach $700?

a clinical-stage biopharmaceutical company

Industry: #Biotechnology
AXON
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
Sep 15, 2026

Can Axon Enterprise (AXON) Stock Reach $700?

Axon Enterprise, Inc. (AXON), the Scottsdale, Arizona–based public safety technology company behind TASER energy weapons, body-worn cameras, and cloud-based evidence management software, has been one of the market's most debated growth names. After a sharp pullback from its 2025 highs, investors are once again asking a pointed question: can AXON realistically climb back to the $700 level?

Key Takeaways

  • With shares trading near $490, a move to $700 implies upside of roughly 40% and would reclaim a key round-number milestone.
  • Wall Street's consensus 12-month price target of approximately $706 sits almost exactly at the $700 level, and the median analyst target is $700.
  • Bullish support comes from 10 consecutive quarters of revenue growth above 30%, a $15 billion contracted backlog, and surging AI and counter-drone demand.
  • Key obstacles include compressed margins, high valuation, dependence on government budgets, and competition from Motorola Solutions.
  • Technical resistance sits near the $600 area, with $700 representing the next major upside zone below the 52-week high of roughly $792.

Company Overview

Founded in 1993 and formerly known as TASER International, Axon has evolved from a single-product hardware maker into an integrated public safety technology platform. Its "razor-and-blades" model sells connected devices—TASERs, body cameras, and drones—that funnel customers into high-margin, recurring software such as Axon Evidence and Draft One. The company holds a dominant share of the U.S. body-camera market and operates through two segments: Software and Services, and Connected Devices.

Why Investors Are Watching the $700 Level

The $700 mark is more than a round psychological number. It aligns almost precisely with the Street's consensus price target of roughly $706 and with the $700 targets reiterated by multiple firms. Crucially, $700 also sits comfortably below Axon's 52-week high of approximately $792 and its all-time high above $880 reached in 2025, making it a realistic recovery objective rather than a fresh record.

Current Market Position

After a volatile stretch, AXON trades around $490, down roughly 20% year to date and well off its 52-week high, though still above its 52-week low near $339. The stock carries a steep trailing price-to-earnings (P/E) ratio above 200, reflecting growth expectations that are priced into the shares rather than near-term earnings power. Its market capitalization stands near $40 billion.

What Could Drive the Next Leg Higher

Axon's fundamentals remain unusually strong for a company of its size. Full-year 2025 revenue grew about 33% to $2.78 billion, and the company has now delivered more than ten straight quarters of revenue growth above 30%. In the second quarter of 2026, revenue rose 35% to roughly $904 million, with annual recurring revenue up 39% to $1.6 billion and net revenue retention of 126%.

Several catalysts could power a move toward $700. AI-driven tools such as Draft One are scaling rapidly, with management reporting AI-related revenue growth approaching 700%. Counter-drone solutions acquired through Dedrone are adding a new growth vector, while international and enterprise bookings have roughly tripled. A contracted backlog of about $15.1 billion—up more than 40% year over year—provides unusual revenue visibility, supporting management's long-term target of roughly $6 billion in revenue by 2028.

What Could Prevent the Move

The path to $700 is not without friction. Gross margins have come under pressure from a heavier mix of lower-margin professional services and the ramp of new hardware. Management has also flagged rising component costs, particularly memory, alongside supply-chain constraints and tariff exposure. These factors make near-term margin expansion less certain than the revenue story.

Valuation remains the biggest structural risk. A trailing P/E above 200 leaves little room for error; any slowdown in bookings, government procurement, or AI adoption could trigger multiple compression. Axon also depends heavily on state, local, and federal budgets, and it competes with MSI (Motorola Solutions) across several product lines. Notable insider selling in recent quarters adds another cautious signal for some investors.

Analyst Opinions and Price Targets

Analyst sentiment is overwhelmingly constructive. The consensus rating is "Buy," and the average 12-month price target is approximately $706, with a median of $700. Targets span a wide range, from a cautious $440 to a bullish $1,000. This clustering around $700 reinforces why the level has become the central question for the stock: it represents the Street's collective base case, not an outlier forecast.

Technical Levels That Matter

From a technical analysis perspective, $700 functions as a logical upside magnet. Resistance is likely to appear first near the $600 area—a zone some valuation models also flag as fair value—before $700 comes into play. On the downside, support is visible in the $440 to $480 range, with the 52-week low near $339 providing a longer-term floor. Reclaiming $600 would be an important first step toward a sustained move to $700.

AI Daily Buy/Sell Signals

Traders seeking an objective view of changing market conditions can turn to Tickeron's AI Daily Buy/Sell Signals. This tool uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving technical behavior and AI-driven analysis. Investors can use these signals to surface new opportunities, monitor existing positions, and identify shifting trends more efficiently than manual screening allows. For those tracking Axon's progress toward the $700 level, a signal-driven framework can help contextualize day-to-day price action within the broader trend.

Final Assessment

A climb to $700 appears achievable but not automatic. Axon's durable backlog, rapid AI and counter-drone adoption, and dominant public safety position provide a credible foundation, and the consensus analyst target essentially endorses the level. However, reaching $700 will likely require sustained 30%-plus revenue growth, a rebound in gross margins as new products scale, and enough investor confidence to support an already-demanding valuation. Investors should monitor future contracted bookings, margin trends, and progress toward the company's 2028 targets. The $700 price target is a reasonable bull case—but it depends on execution rather than momentum.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
AXON
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

AXON and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXON
1D Price
Change %
AXON100%
+2.26%
TECH - AXON
61%
Loosely correlated
+0.21%
VCYT - AXON
58%
Loosely correlated
+0.83%
BEAM - AXON
57%
Loosely correlated
+0.54%
SEER - AXON
56%
Loosely correlated
-2.05%
ADPT - AXON
56%
Loosely correlated
+2.40%
More
Can Axon Enterprise (AXON) Stock Reach $700?